FDA Investigator Monica Commerford, PhD
Monica Commerford, PhD has inspections in 2 countries as of 11 Oct 2023. Monica Commerford, PhD has collaborated with a combinined 1578 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Germany
Co-Investigator(s):
Andrea Franco,
Anh M Lac,
Anita Narula, PhD,
Ann L Demarco,
Azza Talaat,
Bo Chi, PhD,
Brenda W Uratani, PhD,
Christopher Downey, PhD,
Christopher R Czajka,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Dogbeda F Mackenzie,
Donald C Obenhuber, PhD,
Douglas A Campbell,
Dr. Ralph M Bernstein, PhD,
Eliezar Ramos,
Ephrem Hunde, PhD,
Erik W Koester,
Erika V Butler,
Felix Maldonado,
Genoula K Ryan,
Graeme E Price,
Jamie L Dion,
Jeffrey M Watson,
Jeffrey P Raimondi,
John D White,
Julie D Bringger,
Kalavati Suvarna, PhD,
Kathleen M Jordan,
Kathleen R Jones, PhD,
Kevin A Gonzalez,
Kristin M Abaonza,
Kurt A Brorson, PhD,
Lance M De Souza, MBA,
Lauren N Barber,
Marcus F Yambot,
Maria Cruz Fisher,
Maria I Cruz Fisher,
Marion Michaelis,
Mariza M Jafary,
Mark Brunswick, PhD,
Mary E Storch,
Megan A Haggerty,
Michael A Charles,
Michael Shanks, MS,
Michele Dougherty, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Mra Munizn,
Nicholas L Hunt,
Nirjal Bhattarai,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Paul L Bellamy,
Peter E Baker,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Robert J Martin,
Robert W Jennings,
Rose M Ashley,
Sara H Gabel,
Scott R Nichols, PhD,
Sean R Marcsisin,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tracy Denison, PhD,
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Viviana R Ramirez,
Walter N Lange,
Wayne E Seifert,
William V Millar,
Yanming An, PhD,
Ying Xin Fan, PhD,
Zerita White,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD,
Zhongren Wu,
Ziyang Su, PhD
Monica Commerford, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2016 | FDA 483 | KBI Biopharma, Inc. - Form 483, 2016-12-09 |
| April, 2017 | FDA 483 | Boehringer Ingelheim Fremont, Inc. - Form 483, 2017-04-04 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more